HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Warner-Lambert Schick Sales Up 10%, Fueling U.S. Consumer Health Sales

This article was originally published in The Rose Sheet

Executive Summary

Warner-Lambert Schick shaving system/Wilkinson Sword sales increased 10% to $212 mil. in the third quarter, helping to fuel a double-digit jump in U.S. consumer health care sales.

You may also be interested in...



FDA May Amend Anticaries Monograph To Allow Combo Antiplaque Products

FDA may be amenable to an oral rinse product that crosses the anticaries and antiplaque/antigingivitis monographs if studies demonstrate safety and efficacy, agency officials told Warner-Lambert at an OTC "feedback" meeting in Rockville, Md. Oct. 8.

Schick FxDiamond Razor 18% More Durable Than Mach3, W-L Says

Warner Lambert's new Schick FxDiamond wet shave system is the first razor designed with alpha diamond-coated blades to stay sharp longer than ordinary blades, according to the company. The razor will be available in October.

Listerine $100 Mil. Spend In 1999 To Include New Tartar Control Mouthwash

Warner-Lambert has earmarked $100 mil. to advertise and promote the Listerine brand in 1999, a portion of which will be used to market new Listerine Tartar Control Mouthwash.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007305

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel